Prescients luminal shield stent system nets CE Mark

Prescient Medical has received CE Mark approval to commercialize its vProtect Luminal Shield stent system, which may be used in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.

The vProtect Luminal Shield is designed to minimize arterial injury and its consequences, allowing the vessel to regain and maintain healthy physiological function. The device is a low radial force, thin-strut, self-expanding nitinol mesh, designed specifically for softer plaques, according to the Doylestown, Pa.-based company.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.